- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06083077
Chest and Abdominal Wall Strapping in Infant With Bronchiolitis (WRAPITIS)
Effect of Chest and Abdominal Wall Strapping on Ventilation and Work of Breathing in Infants With Severe Bronchiolitis: a Physiological Study
Bronchiolitis is the most common cause of admission to the Paediatric Intensive Care Unit (PICU) for respiratory distress.
The care of an infant with severe bronchiolitis is mainly based on symptomatic treatment (nutritional and respiratory support). The lower part of an infant's chest is larger than that of an older child, which can flatten the diaphragm, especially in obstructive disease with air trapping. Strapping the lower part (at the junction of the chest and abdomen) may provide a better condition for diaphragmatic contraction. Based on respiratory mechanics in infants and physiological studies in adults, investigators hypothesise that chest wall strapping may improve the ventilation and the diaphragmatic contraction.
Infant < 6 month with severe bronchiolitis admitted to the PICU will be recorded in 4 conditions with or without chest wall strapping and with a Continuous Positive Airway Pressure (CPAP) at 7 cmH2O or without CPAP. Physiological parameters (including work of breathing, respiratory parameters, distribution of ventilation) will be recorded and analysed.
Study Overview
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69500
- Réanimation pédiatrique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Infant < 6 months
- Admitted to the PICU for less than 48 hours
- With a diagnosis of bronchiolitis
- With a respiratory distress sign (mWCAS ≥ 3) and non-invasive ventilatory support
- With a naso or oro gastric tube for feeding
- With written informed consent from parents or legal guardians
Exclusion Criteria:
- Infants with severe bronchopulmonary disease, severe laryngomalacia, neuromuscular disease, bone disease, cyanotic heart disease
- Contraindication to the use of a gastric tube
- recent abdominal or thoracic surgery
- investigator able to perform physiological recording not available
- Patient who is not affiliated (or does not benefit from) to a national social security system
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Infant < 6 months with severe bronchiolitis
Infant will be recorded successively in 6 conditions (10 min each) :
|
An elastic band (6 cm wide) is placed around the lower part of the chest wall (at the junction of the chest and abdomen) to tighten the chest wall for 10 min at PEEP 7 cmH2O and 10 min without PEEP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Esophagal product time pressure
Time Frame: 1 hour
|
Average over 100 consecutive cycles of esophageal product time pressure value
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragmatic product time pressure
Time Frame: 1 hour
|
Average over 100 consecutive cycles of diaphragmatic product time pressure value
|
1 hour
|
|
Esophagal and diaphragmatic swing
Time Frame: 1 hour
|
Mean on 100 breaths of the amplitude (maximum value -minimum value) of the esophageal pressure (cmH2O) and gastric pressure (cmH2O)
|
1 hour
|
|
Distribution of ventilation : center of ventilation
Time Frame: 1 hour
|
Mean over 1 minute of the center of the ventilation (%).
Center of ventilation represents the average of the dorsal-ventral distribution of tidal variation using Electrical Impedance Tomography (values >50% indicating that the center of ventilation is located in the ventral part of the chest)
|
1 hour
|
|
End expiratory lung volume
Time Frame: 1 hour
|
Average over 1 minute of the end expiratory lung impedance
|
1 hour
|
|
Time ratio
Time Frame: 1 hour
|
average over 100 consecutive cycles of inspiratory to aspiratory time ratio
|
1 hour
|
|
modified wood asthma score (mWCAS)
Time Frame: 1 hour
|
Value of the modified wood asthma score at the end of the recording period in each condition. Minimal value 0 and maximal value 10. A score ≥ 3 mean a moderate-to-severe respiratory distress. |
1 hour
|
|
TcPCO2
Time Frame: 1 hour
|
Average of the transcutaneous CO2 (carbon dioxide) partial over 1 minute
|
1 hour
|
|
EDIN scale (Newborn Pain and Discomfort Scale)
Time Frame: 1 hour
|
Value of the EDIN score at the end of the recording period in each condition.
Minimal value 0 and maximal value 15.
EDIN scores > 6 are considered expression of pain
|
1 hour
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL23_0821
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
Regend TherapeuticsShanghai Children's HospitalRecruitingPediatric Bronchiolitis ObliteransChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaCompletedBronchiolitis Obliterans Syndrome (BOS)Italy
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
Clinical Trials on Chest wall strapping
-
University of Health Sciences LahoreRecruitingMalignancy | Reconstructive Surgical Procedure | Chest Wall TumorPakistan
-
University of Health Sciences LahoreCompletedChest Wall Disease | Chest Wall Tumor | Chest Wall Mechanics | Chest Wall DeformityPakistan
-
Hui-Ling LinCompleted
-
Tang-Du HospitalNot yet recruiting
-
Ege UniversityCompletedTrauma | Rib FracturesTurkey
-
Universitätsklinikum Hamburg-EppendorfCompletedFunnel Chest | Chest Wall DeformityGermany
-
Heart of England NHS TrustUniversity of Warwick; University of BirminghamCompletedLung Neoplasms | Pulmonary Disease, Chronic Obstructive | Surgery | Cystic Fibrosis | Mesothelioma | Empyema, Pleural | Pectus Excavatum | Pectus CarinatumUnited Kingdom
-
Regina Elena Cancer InstituteValeria Landoni; Diana Giannarelli; Giuseppe Sanguineti; Silvia Takanen; Serena Nucciarelli and other collaboratorsCompleted
-
McGill UniversityUnknown
-
Stony Brook UniversityWithdrawnBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | DCISUnited States